Zymedi Email Formats
Pharmaceutical Manufacturing • 
85 Songdokwahak-ro Yeonsu-gu, Posco Green Building (Bldg 511), Korea, Republic of • 1-10 Employees
Key Contacts at Zymedi
Scott Kim
Chief Business Officer I Managing Director I Head Of Business Development & Strategy
Sunghoon Kim
Ceo
Minjo Kim
General Counsel | Director Of Strategy & Planning
Choulhong Park
Director
Company overview
| Headquarters | 85 Songdokwahak-ro Yeonsu-gu, Posco Green Building (Bldg 511), Incheon, - None - 21983, KR |
| Phone number | +82328228376 |
| Website | |
| NAICS | 3254 |
| Keywords | ARS, Kars1, Zm-A001, Zm-C001, Zm-C101 |
| Founded | 2019 |
| Employees | 1-10 |
| Socials |
About Zymedi
Zymedi is a clinical-stage biopharmaceutical company focused on transforming the role of ARSs (Aminoacyl-tRNA Synthetases) as a novel target for discovering and developing treatments for serious, life-threatening conditions lacking effective therapies or standard care. Our lead asset, ZMA001, is a first-in-class therapeutic that targets Lysyl-tRNA synthetase 1 (KARS1). By controlling monocyte and macrophage infiltration to inhibit inflammation in pulmonary blood vessels, ZMA001 is being developed as a treatment for pulmonary arterial hypertension (PAH). Currently in Phase I trials through a CRADA with the U.S. NIH, ZMA001 shows promise in addressing the root causes of PAH, a market projected to reach $9.7 billion by 2028.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Zymedi has 6 employees across 5 departments.
Departments
Number of employees
Zymedi Tech Stack
Discover the technologies and tools that power Zymedi's digital infrastructure, from frameworks to analytics platforms.
Video players
JavaScript libraries
Web servers
WordPress themes
JavaScript libraries
Programming languages
Blogs
UI frameworks
Video players
SEO
Photo galleries
United Kingdom
United States
Germany
South AfricaFrequently asked questions
4.8
40,000 users
